MDR1, MRP1 and MRP2 genotypes and in vitro chemosensitivity in Japanese patients with colorectal adenocarcinomas

Kobe Journal of Medical Sciences

Volumn 50, Issue 6, 2004, Pages 181-188

  Nishioka, Chiharu ^a   Sakaeda, Toshiyuki ^b   Nakamura, Tsutomu ^b   Moriya, Yuka ^b   Okamura, Noboru ^b   Tamura, Takao ^a   Nakahara, Takako ^a   Aoyama, Nobuo ^b   Kamigaki, Takashi ^a   Ohno, Masakazu ^a   Kuroda, Yoshikazu ^a   Kasuga, Masato ^a   Okumura, Katsuhiko ^b  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

CD DST; Chemosensitivity; Human colorectal adenocarcinomas; MDR1; MRP1; MRP2

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; CISPLATIN; FLUOROURACIL; MESSENGER RNA; MITOMYCIN C; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2;

ARTICLE; CANCER GROWTH; CHEMOSENSITIVITY; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG SENSITIVITY; EVALUATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; GROWTH RATE; HUMAN; HUMAN TISSUE; PHARMACOGENETICS; PROTEIN EXPRESSION;

ADENOCARCINOMA; COLORECTAL NEOPLASMS; GENOTYPE; HUMANS; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN;

EID: 24644452967     PISSN: 00232513     EISSN: 18830498     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bogden A. E., W. Griffin, S.D. Reich, M.E. Costanza, and W.R. Cobb. 1984. Predictive testing with the subrenal capsule assay. Cancer Treatment Rev. 11(supplement A):113-124.
2. Chu X.Y., Y. Kato, and Y. Sugiyama 1997. Multiplicity of biliary excretion mechanisms for irinotecan, CPT-11, and its metabolites in rats. Cancer Res. 57:1934-1938.
3. Evans W. E., and H.L. McLeod. 2003. Pharmacogenomics - drug disposition, drug targets, and side effects. N. Engl. J. Med. 348:538-549.
4. Freeman A. E., and R.M. Hoffman. 1986. In vivo-like growth of human tumors in vitro. Proc. Natl. Acad. Sci. USA 83:2694-2698.
5. Hanatani Y., H. Kobayashi, S. Kodaira, H. Takami, T. Asagoe, and E. Kaneshiro. 2000. An in vitro chemosensitivity test for gastric cancer using collagen gel droplet embedded culture. Oncol. Rep. 7:1027-1033.
6. Higashiyama M., K. Kodama, H. Yokouchi, K. Takami, O. Doi, H. Kobayashi, K. Tanisaka, and K. Minamigawa 1998. Immunohistochemical p53 protein status in nonsmall cell lung cancer is a promising indicator in determining in vitro chemosensitivity to some anticancer drugs. J. Surg. Oncol. 68:19-24.
7. Hinoshita E., T. Uchiumi, K. Taguchi, N. Kinukawa, M. Tsuneyoshi, Y. Maehara, K. Sugimachi, and M. Kuwano. 2000. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinoma. Clin. Cancer Res. 6: 2401-2407.
8. Horinouchi M., T. Sakaeda, T. Nakamura, Y. Morita, T. Tamura, N. Aoyama, M. Kasuga, and K. Okumura Significant genetic linkage of MDR1 polymorphisms at positions 3435 and 2677: functional relevance to pharmacokinetics of digoxin. Pharm. Res. 19:1581-1585.
9. Ito S., I. Ieiri, M. Tanabe, A. Suzuki, S. Higuchi, and K. Otsubo 2001. Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects. Pharmacogenetics. 11:171-184.
10. Kobayashi H., M. Higashiyama, K. Minamigawa K. Tanisaka, T. Takano, H. Yokouchi, K. Kodama, and T. Hata 2001. Examination of in vitro chemosensitivity test using collagen gel droplet culture method with colorimetric endpoint quantification. Jpn. J. Cancer Res. 92:203-210.
11. Kobayashi H., K. Tanisaka, O. Doi, K. Kodama, M. Higashiyama, H. Nakagawa, M. Miyake, T. Taki, S. Hara, M. Yasutomi, Y. Hanatani, K. Kotake, and T. Kubota. 1997. An in vitro chemosensitivity test for solid human tumors using collagen gel droplet embedded cultures. Int. J. Oncol. 11:449-455.
12. Kondo T., T. Imamura, and H. Ishihashi. 1966. In vitro test for sensitivity of tumor to carcinostatic agents. Jpn. J. Cancer Res. (Gann), 57:113-121.
13. Morita Y., T. Sakaeda, M. Horinouchi, T. Nakamura, K. Kuroda, I. Miki, K. Yoshimura, T. Sakai, D. Shirasaka, T. Tamura, N. Aoyama, M. Kasuga, and K. Okumura. 2003. MDR1 genotype-related duodenal absorption rate of digoxin in healthy Japanese subjects. Pharm. Res. 20:552-556.
14. Mosmann T. 1983. Rapid colorometric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:55-63.
15. Nakahara T., T. Sakaeda, T. Nakamura, T. Tamura, C. Nishioka, N. Aoyama, N. Okamura, T. Shirakawa, A. Gotoh, T. Kamigaki, M. Ohno, Y. Kuroda, M. Matsuo, M. Kasuga, and K. Okumura. 2004. Chemosensitivity assessed by collagen gel droplet embedded culture drug sensitivity test, and MDR1, MRP1, and MRP2 mRNA expression in human colorectal adenocarcinomas. Pharm. Res. 21:406-412.
16. Nakamura T., T. Sakaeda, N. Ohmoto, T. Tamura, N. Aoyama, T. Shirakawa, T. Kamigaki, T. Nakamura, K.I. Kim, S.R. Kim, Y. Kuroda, M. Matsuo, M. Kasuga, and K. Okumura. 2002. Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas. Drug Metab. Dispos. 30:4-6.
17. Nakamura T., T. Sakaeda, M. Horinouchi, T. Tamura, N. Aoyama, T. Shirakawa, M. Matsuo, M. Kasuga, and K. Okumura. 2002. Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects. Clin. Pharmacol. Ther. 71:297-303.
18. Sakaeda T., T. Nakamura, and K. Okumura. 2002. MDR1 genotype-related pharmacokinetics and pharmacodynamics. Biol. Pharm. Bull. 25:1391-1400.
19. Sakaeda T., T. Nakamura, and K. Okumura. 2003. Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs. Pharmacogenomics. 4:397-410.
20. Sakaeda T., T. Nakamura, and K. Okumura. 2004. Pharmacogenetics of drug transporters and its impact on the pharmacotherapy. Curr. Top. Med. Chem. 4:1385-1398.
21. Sakaeda T., T. Nakamura, M. Hirai, T. Kimura, A. Wada, T. Yagami, H. Kobayashi, S. Nagata, N. Okamura, T. Yoshikawa, T. Shirakawa, A. Gotoh, M. Matsuo, and K. Okumura. 2002. MDR1 up-regulated by apoptotic stimuli suppresses apoptotic signaling. Pharm. Res. 19:1323-1329.
22. Sakaeda T., T. Nakamura, M. Horinouchi, M. Kakumoto, N. Ohmoto, T. Sakai, Y. Morita, T. Tamura, N. Aoyama, M. Hirai, M. Kasuga, and K. Okumura. 2001. MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects. Pharm. Res. 18:1400-1404.
23. Salmon S. E., A.W. Hamburger, B. Soehnlen, B.G.M. Durie, D.S. Alberts, and T.E. Moon. 1978. Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. N. Engl. J. Med. 298:1321-1327.
24. Tanigawa N., D. H. Kern, Y. Hikasa, and D. L. Morton: Rapid assay for evaluating the chemosensitivity of human tumors in soft agar culture. Cancer Res. 42: 2159-2164 (1982).
25. Tirona R.G., and R.B. Kim. 2002. Pharmacogenomics of drug transporters, p. 179-213. In Licinio J. and Wong M.-L. (ed.): Pharmacogenomics. The Search for Individualized Therapies, Wiley-VCH Verlag GmbH, Germany.
26. Vescio R.A., C.H. Redfern, T.J. Nelson, S. Ugoretz, P.H. Stern, and R.M. Hoffman. 1987. In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture. Proc. Natl. Acad. Sci. USA 84:5029-5033.
27. Yasuda H., T. Takada, K. Wada, H. Amano, T. Isaka, M. Yoshida, T. Uchida, and N. Toyota. 1998. A new in-vitro drug sensitivity test (collagen-gel droplet embedded-culture drug sensitivity test) in carcinomas of pancreas and biliary tract: possible clinical utility. J. Hepatobiliary Pancreat. Surg. 5:261-268.